168 related articles for article (PubMed ID: 36522176)
1. Implementation of an ISO15189 accredited next-generation sequencing service with the fully automated Ion Torrent Genexus: the experience of a clinical diagnostic laboratory.
Werner R; Connolly A; Bennett M; Hand CK; Burke L
J Clin Pathol; 2024 Mar; 77(4):278-283. PubMed ID: 36522176
[TBL] [Abstract][Full Text] [Related]
2. Clinical validation of the Ion Torrent Oncomine Myeloid Assay GX v2 on the Genexus Integrated Sequencer as a stand-alone assay for single-nucleotide variants, insertions/deletions, and fusion genes: Challenges, performance, and perspectives.
Krishnamurthy K; Chai J; Liu X; Wang Y; Naeem R; Goldstein DY
Am J Clin Pathol; 2024 Jun; ():. PubMed ID: 38823030
[TBL] [Abstract][Full Text] [Related]
3. European Real-World Assessment of the Clinical Validity of a CE-IVD Panel for Ultra-Fast Next-Generation Sequencing in Solid Tumors.
Normanno N; Machado JC; Pescarmona E; Buglioni S; Navarro L; Esposito Abate R; Ferro A; Mensink R; Lambiase M; Lespinet-Fabre V; Calgua B; Jermann PM; Ilié M; Hofman P
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762091
[TBL] [Abstract][Full Text] [Related]
4. Ion Torrent ™ Genexus ™ Integrated Sequencer and ForeNGS Analysis Software-An automatic NGS-STR workflow from DNA to profile for forensic science.
Guo F; Lang Y; Long G; Liu Z; Jing G; Zhou Y; Zhang B; Yu S
Forensic Sci Int Genet; 2022 Nov; 61():102753. PubMed ID: 35931007
[TBL] [Abstract][Full Text] [Related]
5. Rapid genomic profiling of circulating tumor DNA in non-small cell lung cancer using Oncomine Precision Assay with Genexus™ integrated sequencer.
Low SK; Ariyasu R; Uchibori K; Hayashi R; Chan HT; Chin YM; Akita T; Harutani Y; Kiritani A; Tsugitomi R; Manabe R; Ogusu S; Amino Y; Kitazono S; Yanagitani N; Nakamura Y; Nishio M
Transl Lung Cancer Res; 2022 May; 11(5):711-721. PubMed ID: 35693289
[TBL] [Abstract][Full Text] [Related]
6. Validation of the Oncomine
Williams HL; Walsh K; Diamond A; Oniscu A; Deans ZC
Virchows Arch; 2018 Oct; 473(4):489-503. PubMed ID: 30105577
[TBL] [Abstract][Full Text] [Related]
7. Versatile ion S5XL sequencer for targeted next generation sequencing of solid tumors in a clinical laboratory.
Mehrotra M; Duose DY; Singh RR; Barkoh BA; Manekia J; Harmon MA; Patel KP; Routbort MJ; Medeiros LJ; Wistuba II; Luthra R
PLoS One; 2017; 12(8):e0181968. PubMed ID: 28767674
[TBL] [Abstract][Full Text] [Related]
8. A Targeted High-Throughput Next-Generation Sequencing Panel for Clinical Screening of Mutations, Gene Amplifications, and Fusions in Solid Tumors.
Luthra R; Patel KP; Routbort MJ; Broaddus RR; Yau J; Simien C; Chen W; Hatfield DZ; Medeiros LJ; Singh RR
J Mol Diagn; 2017 Mar; 19(2):255-264. PubMed ID: 28017569
[TBL] [Abstract][Full Text] [Related]
9. Rapid and Automated Semiconductor-Based Next-Generation Sequencing for Simultaneous Detection of Somatic DNA and RNA Aberrations in Myeloid Neoplasms.
Sande CM; Wu R; Yang G; Sussman RT; Bigdeli A; Rushton C; Chitturi A; Patel J; Szankasi P; Morrissette JJD; Lim MS; Elenitoba-Johnson KSJ
J Mol Diagn; 2023 Feb; 25(2):87-93. PubMed ID: 36503148
[TBL] [Abstract][Full Text] [Related]
10. Single-Center Experience with a Targeted Next Generation Sequencing Assay for Assessment of Relevant Somatic Alterations in Solid Tumors.
Paasinen-Sohns A; Koelzer VH; Frank A; Schafroth J; Gisler A; Sachs M; Graber A; Rothschild SI; Wicki A; Cathomas G; Mertz KD
Neoplasia; 2017 Mar; 19(3):196-206. PubMed ID: 28161563
[TBL] [Abstract][Full Text] [Related]
11. Point of Care Molecular Testing: Community-Based Rapid Next-Generation Sequencing to Support Cancer Care.
Sheffield BS; Beharry A; Diep J; Perdrizet K; Iafolla MAJ; Raskin W; Dudani S; Brett MA; Starova B; Olsen B; Cheema PK
Curr Oncol; 2022 Feb; 29(3):1326-1334. PubMed ID: 35323313
[No Abstract] [Full Text] [Related]
12. Analytical Validation of an Automated Semiconductor-Based Next-Generation Sequencing Assay for Detection of DNA and RNA Alterations in Myeloid Neoplasms.
Zbieranski N; Insuasti-Beltran G
J Mol Diagn; 2024 Jan; 26(1):29-36. PubMed ID: 37879438
[TBL] [Abstract][Full Text] [Related]
13. Quality metrics for enhanced performance of an NGS panel using single-vial amplification technology.
Barua S; Hsiao S; Clancy E; Freeman C; Mansukhani M; Fernandes H
J Clin Pathol; 2023 Dec; 77(1):46-53. PubMed ID: 36376073
[TBL] [Abstract][Full Text] [Related]
14. Implementation of next generation sequencing technology for somatic mutation detection in routine laboratory practice.
Giardina T; Robinson C; Grieu-Iacopetta F; Millward M; Iacopetta B; Spagnolo D; Amanuel B
Pathology; 2018 Jun; 50(4):389-401. PubMed ID: 29752127
[TBL] [Abstract][Full Text] [Related]
15. Validation and optimization of the Ion Torrent S5 XL sequencer and Oncomine workflow for BRCA1 and BRCA2 genetic testing.
Shin S; Kim Y; Chul Oh S; Yu N; Lee ST; Rak Choi J; Lee KA
Oncotarget; 2017 May; 8(21):34858-34866. PubMed ID: 28422718
[TBL] [Abstract][Full Text] [Related]
16. Analytical Validation of the Next-Generation Sequencing Assay for a Nationwide Signal-Finding Clinical Trial: Molecular Analysis for Therapy Choice Clinical Trial.
Lih CJ; Harrington RD; Sims DJ; Harper KN; Bouk CH; Datta V; Yau J; Singh RR; Routbort MJ; Luthra R; Patel KP; Mantha GS; Krishnamurthy S; Ronski K; Walther Z; Finberg KE; Canosa S; Robinson H; Raymond A; Le LP; McShane LM; Polley EC; Conley BA; Doroshow JH; Iafrate AJ; Sklar JL; Hamilton SR; Williams PM
J Mol Diagn; 2017 Mar; 19(2):313-327. PubMed ID: 28188106
[TBL] [Abstract][Full Text] [Related]
17. Targeted Next Generation Sequencing as a Reliable Diagnostic Assay for the Detection of Somatic Mutations in Tumours Using Minimal DNA Amounts from Formalin Fixed Paraffin Embedded Material.
de Leng WW; Gadellaa-van Hooijdonk CG; Barendregt-Smouter FA; Koudijs MJ; Nijman I; Hinrichs JW; Cuppen E; van Lieshout S; Loberg RD; de Jonge M; Voest EE; de Weger RA; Steeghs N; Langenberg MH; Sleijfer S; Willems SM; Lolkema MP
PLoS One; 2016; 11(2):e0149405. PubMed ID: 26919633
[TBL] [Abstract][Full Text] [Related]
18. Analytical validation and implementation of a pan cancer next-generation sequencing panel, CANSeq
Schilter KF; Smith BA; Nie Q; Stoll K; Felix JC; Jarzembowski JA; Reddi HV
Front Genet; 2023; 14():1067457. PubMed ID: 36845394
[TBL] [Abstract][Full Text] [Related]
19. Performance of non-formalin fixed paraffin embedded samples in hybrid capture and amplicon next-generation sequencing panels.
Meireles SI; Cruz MV; de Godoy CD; de Testagrossa L
Diagn Cytopathol; 2024 Mar; 52(3):171-182. PubMed ID: 38124281
[TBL] [Abstract][Full Text] [Related]
20. Next-Generation Sequencing Workflow for NSCLC Critical Samples Using a Targeted Sequencing Approach by Ion Torrent PGM™ Platform.
Vanni I; Coco S; Truini A; Rusmini M; Dal Bello MG; Alama A; Banelli B; Mora M; Rijavec E; Barletta G; Genova C; Biello F; Maggioni C; Grossi F
Int J Mol Sci; 2015 Dec; 16(12):28765-82. PubMed ID: 26633390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]